Rapid isolation of muscle and heart mitochondria, the lability of oxidative phosphorylation and attempts to stabilize the process in vitro by taurine, carnitine and other compounds

Molecular and Cellular Biochemistry

Volumn 174, Issue 1-2, 1997, Pages 61-66

  Scholte, Hans R ^a   Yu, Yihong ^b   Ross, John D ^b   Oosterkamp, Imma I ^b   Boonman, Adriana M C ^b   Busch, Herman F M ^b  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b NONE

Author keywords

Heart mitochondria; Lability; Muscle mitochondria; Oxidative phosphorylation; Stability; Taurine

Indexed keywords

21 [4 [2,6 BIS(1 PYRROLIDINYL) 4 PYRIMIDINYL] 1 PIPERAZINYL]PREGNA 1,4,9(11) TRIENE 3,20 DIONE; 21 [4 [5,6 BIS(DIETHYLAMINO) 2 PYRIDYL] 1 PIPERAZINYL] 16ALPHA METHYLPREGNA 1,4,9(11) TRIENE 3,20 DIONE; ACETYLCARNITINE; ASCORBIC ACID; CALCIUM ION; CARNITINE; CREATINE PHOSPHATE; DEFEROXAMINE; GLUTAMIC ACID; LAZAROID; PALMITOYLCARNITINE; PYRUVIC ACID; REACTIVE OXYGEN METABOLITE; RUTHENIUM RED; SUCCINIC ACID; TAURINE; TROLOX C;

ANIMAL TISSUE; ARTICLE; COLD; CONTROLLED STUDY; DARKNESS; HEART MITOCHONDRION; HUMAN; HUMAN TISSUE; ISOLATION PROCEDURE; KINETICS; MALE; MITOCHONDRIAL MYOPATHY; MUSCLE; MUSCLE MITOCHONDRION; NONHUMAN; OXIDATION; OXIDATIVE PHOSPHORYLATION; RAT; STORAGE; TECHNIQUE;

ANIMALS; CARNITINE; CELL FRACTIONATION; HUMANS; MITOCHONDRIA, HEART; MITOCHONDRIA, MUSCLE; OXIDATIVE PHOSPHORYLATION; RATS; RATS, WISTAR; TAURINE;

ANIMALIA;

EID: 0030882396     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006803807814     Document Type: Article

References (25)

1. Bookelman H, Trijbels JMF, Sengers RCA, Janssen AJM: Measurement of cytochromes in human skeletal muscle mitochondria, isolated from fresh and frozen stored muscle specimens. Biochem Med 19: 366-373, 1978
2. Luft R, Ikkos D, Palmieri G, Ernster L, Afzelius B: A case of severe hypermetabolism of nonthyroid origin with a defect in the maintenance of mitochondrial respiratory control: a correlated clinical, biochemical and morphological study. J Clin Invest 41: 1776-1804, 1962
3. Dow DS: The isolation of skeletal muscle mitochondria showing tight coupling. High respiratory indices, and differential adenosine triphosphatase activities. Biochemistry 6: 2915-2922, 1967
4. Lowenstein J, Scholte HR, Wit-Peeters EM: A rapid and simple procedure to deplete rat-liver mitochondria of lysosomal activity. Biochim Biophys Acta 223: 432-436, 1970
5. De Duve C, Berthet J: Reproducibility of differential centrifugation experiments in tissue fractionation. Nature 172: 1142, 1953
6. Srere PA. Citrate synthase. Meth Enzymol 13: 3-26, 1969
7. Jansen TC, Lafeber HN, Visser HKA, Kwant G, Oeseburg B, Zijlstra WG: Construction and performance of a new catheter-tip oxygen electrode. Med Biol Eng Comput 16: 274-277, 1978
8. Scholte HR, Busch HFM, Luyt-Houwen IEM: Functional disorders of mitochondria in muscular diseases-respiratory chain phosphorylation-the carnitine system. In: HEM Busch, FGI Jennekens, HR Scholte (eds). Mitochondria and Muscular Diseases. Mefar b.v., Beetsterszwaag, The Netherlands, 1981, pp 133-145
9. Barth PG, Scholte HR, Berden JA, Van Der Klei-Van Moorsel JM, Luyt-Houwen IEM, Van't Veer-Korthof ET, Van Der Harten JJ, Sobotka-Plojhar MA: An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes. J Neurol Sci 62: 327-355, 1983
10. Scholte HR, Agsteribbe E, Busch HFM, Hoogenraad TU, Jennekens FGI, van Linge B, Luyt-Houwen IEM, Ross JD, Ruiters MHJ, Verduin MHM: Oxidative phosphorylation in human muscle in patients with ocular myopathy and after general anaesthesia. Biochim Biophys Acta 1018: 211-216, 1990
11. Di Lisa F, Bobyleva-Guarriero V, Jocelyn P, Toninello A, Siliprandi N: Stabilizing action of carnitine on energy linked processes in rat liver mitochondria. Biochem Biophys Res Commun 131: 968-973, 1985
12. Van der Kraaij AMM, Mostert LJ, Van Eijk HG, Koster JF: Iron-load increases the susceptibility of rat hearts to oxygen reperfusion damage. Protection by the antioxidant (+)-cyanidanol-3 and deferoxamine. Circulation 78: 442-449
13. Van Jaarsveld H, Kuyt JM, Alberts DW: The protective effect of desferal on rat myocardial mitochondria is not prolonged after withdrawal of desferal. Basic Res Cardiol 87: 47-53, 1992
14. Dennerlein JA, Lang GE, Stahnke K, Kleihauer E, Lang GK: Okulare Befunde bei Desferaltherapie. Ophthalmologie 92: 38-42, 1995
15. Cianciulli P, Sollecito D, Sorrentino F, Forte L, Gilardi E, Massa A, Papa G, Carta S: Early detection of nephrotoxic effects in thalassemic patients receiving desferrioxamine therapie. Kidney Int 46: 467-470, 1994
16. Huxtable RJ: Physiological actions of taurine. Physiol Rev 72: 101-163, 1992
17. Huxtable RJ, Michalk D (eds): Taurine in health and disease. Adv Exp Med Biol 359: 1-458, 1994
18. Hall ED, McCall JM: Antioxidant action of lazaroids. Meth Enzymol 234: 548-555, 1994
19. Pakala R, Pakala R, Benedict CR: Novel 21-aminosteroidlike compounds prevent iron-induced free radical-mediated injury to vascular endothelial cells. J Cardiovasc Pharmacol 25: 871-879, 1995
20. Bakker HD, Scholte HR, Jeneson JAL: Vitamin E in a mitochondrial myopathy with proliferating mitochondria. The Lancet 342: 175-176, 1993
21. 31P magnetic resonance spectroscopy during treatment with nicotinamide and riboflavin. Neurology 42: 2147-2152, 1992
22. Peterson PL: The treatment of mitochondrial myopathies and encephalopathies. Biochim Biophys Acta 1271: 275-280, 1995
23. Przyrembel H: Therapy of mitochondrial disorders. J Inher Metab Dis 10, Suppl 1: 129-146, 1987
24. Scholte HR, Busch HFM, Bakker HD, Bogaard JM, Luyt-Houwen IEM, Kuyt LP: Riboflavin-responsive complex I deficiency. Biochim Biophys Acta 1271: 75-83, 1995
25. Kraft A, v. Wersebe O, Neudecker S, Hein W, Haunschild M, Skladal D, Sperl W, Gnaiger E, Margreiter R, Zierz S, Gellerich FN: Long term stability of mitochondrial functions in human skeletal muscle fibers during cold storage. J Mol Med 73: B45, 1995